HomeCompareSPRQF vs JNJ

SPRQF vs JNJ: Dividend Comparison 2026

SPRQF yields 460.19% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPRQF wins by $32522.94M in total portfolio value
10 years
SPRQF
SPRQF
● Live price
460.19%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32522.96M
Annual income
$22,783,765,620.31
Full SPRQF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPRQF vs JNJ

📍 SPRQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPRQFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPRQF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPRQF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPRQF
Annual income on $10K today (after 15% tax)
$39,116.43/yr
After 10yr DRIP, annual income (after tax)
$19,366,200,777.26/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SPRQF beats the other by $19,366,200,073.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPRQF + JNJ for your $10,000?

SPRQF: 50%JNJ: 50%
100% JNJ50/50100% SPRQF
Portfolio after 10yr
$16261.49M
Annual income
$11,391,883,224.04/yr
Blended yield
70.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPRQF
No analyst data
Altman Z
48.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPRQF buys
0
JNJ buys
0
No recent congressional trades found for SPRQF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPRQFJNJ
Forward yield460.19%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$32522.96M$20.0K
Annual income after 10y$22,783,765,620.31$827.78
Total dividends collected$31659.14M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPRQF vs JNJ ($10,000, DRIP)

YearSPRQF PortfolioSPRQF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$56,719$46,019.33$10,676$355.77+$46.0KSPRQF
2$304,632$243,942.56$11,407$389.39+$293.2KSPRQF
3$1,550,428$1,224,471.22$12,198$426.53+$1.54MSPRQF
4$7,483,214$5,824,256.10$13,056$467.62+$7.47MSPRQF
5$34,279,050$26,272,010.79$13,987$513.12+$34.27MSPRQF
6$149,152,069$112,473,486.15$14,998$563.56+$149.14MSPRQF
7$616,961,888$457,369,173.60$16,098$619.52+$616.95MSPRQF
8$2,428,270,969$1,768,121,749.79$17,295$681.69+$2428.25MSPRQF
9$9,102,050,271$6,503,800,334.03$18,599$750.82+$9102.03MSPRQF
10$32,522,959,411$22,783,765,620.31$20,022$827.78+$32522.94MSPRQF

SPRQF vs JNJ: Complete Analysis 2026

SPRQFStock

SPARQ Corp. designs, manufactures, and sells single-phase microinverters for residential and commercial solar electric applications. It offers Quad inverters, a proprietary photovoltaic solution. The company was founded in 2009 and is headquartered in Kingston, Canada.

Full SPRQF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPRQF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPRQF vs SCHDSPRQF vs JEPISPRQF vs OSPRQF vs KOSPRQF vs MAINSPRQF vs ABBVSPRQF vs MRKSPRQF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.